newsfilter
← Latest News
GlobeNewswire·

Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand

  • Nanox AI Ltd. announced a commercial collaboration with Thailand-based Dosy Health to introduce and commercialize its CT-based cardiac solution, HealthCCSng, in Thailand.
  • The parties signed a distribution agreement to expand Nanox AI's international footprint and bring imaging analytics to new healthcare markets.
  • Dosy Health leverages existing relationships with Mahidol University, Thammasat University, and hospitals within the BDMS network to support market engagement & integration.
  • Preliminary hospital interest was expressed following Dosy Health's CEO Sahatus Asawadilockchai's participation in the Global Medical AI Summit in Thailand.
  • HealthCCSng analyzes routine non-contrast, non-gated CT scans to provide coronary artery calcium measurements & categorization for clinician review.
  • Nanox CEO Erez Meltzer stated the partnership aims to combine imaging analytics with Dosy's local market knowledge to build a foundation for future commercial opportunities.
  • Dosy CEO Sahatus Asawadilockchai highlighted Thailand's high CT scanner density as an opportunity to unlock clinical value, noting plans to start with cardiac imaging & explore bone & liver imaging later.
  • Future commercialization is subject to definitive agreements, regulatory requirements, & market-development progress.
  • Nanox (NASDAQ: NNOX) operates an integrated platform combining hardware, AI, cloud software, & health IT to enable preventive care.
  • Nanox.AI is the subsidiary developing deep-learning algorithms to extract actionable insights from medical imaging for chronic & acute diseases.
  • The press release includes forward-looking statements regarding development, commercialization, & regulatory approvals that are subject to risks & uncertainties.
Company
NANO-X IMAGING LTD
Keywords
Nasdaq:NNOX, NANO-X IMAGING LTD